Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2174)	1/22/2008 10:09:40 AM
From: Jibacoa	Respond to of 3722

VMSI is up 4.17% after it finally agreed to get munched by Roche.<g> stockcharts.com Roche raised its offer by about 19% to $89.50( about $3.4B) Bernard

To: Jibacoa who wrote (2174)	2/11/2008 5:25:13 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

MITI was up for 4th day o a roll as it continued to bounce up from the $1.50 level, but it wasn't able to deal with the resistance at $2 The stock was up 16.18% at its intraday H of $2.01 but closed up only 9.83% The volume of 68,822 was > its ADV of 44Ks bigcharts.marketwatch.com Its CEO is scheduled to present at the BIO CEO and Investor Conference in NY on Wednesday, & will also present at the Roth Capital's Growth Stock Conference in CA, a week from tomorrow. As previously mentioned, MITI has trimmed some of its losses in the las 2Qs & revenues were also better on the last (3rd) Q, but it isn't expected to show a good comparison in the pending 4thQ when revenues had a spike of 59% & earnings were up 185% in 2006 <g> The stock trades around 2.7xBV The insiders hold >25% & the short ratio is around 7x its ADV. The "analysts" have a target of $4.35 but I would just keep it around the May H of $3.25 <g> bigcharts.marketwatch.com Bernard